Clinical trial
KRN5500 in Treating Patients With Metastatic Solid Tumors
NCT00002923 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00002923 |
|---|---|
| Title | KRN5500 in Treating Patients With Metastatic Solid Tumors |
| Official title | Phase I Evaluation of KRN5500 (NSC650426) |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | KRN5500 |
| Enrollment | 27 |
| Start date | May 1, 1997 |
| Primary completion | Jan 1, 2000 |
| Completion | Oct 1, 2000 |
| First posted | May 26, 2004 |
| Last update posted | Apr 25, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: